Compex is set to merge with a competitor in the electro-stimulation sector, Cefar AB. Encore Medical Corp., which took over Compex’ parent company a few months ago, has agreed to buy Cefar from a Swedish investment fund. Together, Compex and Cefar reportedly have annual sales of about €40 million. The ...
Register a free account or login to unlock 3 more articles each week
SIGN-IN if you are already a subscriber of SGI Europe.

Already a subscriber? Sign in
Ready for unlimited coverage?
Upgrade to Professional or Premium for unlimited access to exclusive reports,
C-suite interviews, market analysis, and industry-wide research—with team licensing included.
Already registered? Sign in here